A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04594928 · COMPLETED
Trial details
- NCT number
- NCT04594928
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2021-05-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.